South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic ...

South Africa is in discussions with Gilead Sciences (GILD) to reach an agreement that allows the production of the U.S. biotech’s new twice-yearly HIV therapy, lenacapavir, in the country, home to the ...

South Africa is asking local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, domestically, in a push to bring production ‌to the region where it is ...

South Africa has the world’s highest HIV burden, with about 8 million HIV-positive people, or 1 in 5 adults, as of last year.

Add Yahoo as a preferred source to see more of our stories on Google. Patrick Arbuthnot was browsing his emails on what seemed like a normal workday in his lab in Johannesburg when he saw a strange ...

UMZIMKHULU, South Africa (AP) — At a rural village in South Africa's KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for the one-hour ride ...

While there are fewer men living with HIV than women, data shows that more men die of Aids. Experts and organisations fighting against the HIV/Aids pandemic have urged men to take treatment to avoid ...

According to The Witness, statistics released by Thembisa, the mathematical model of HIV and TB in South Africa, show that in ...

HARARE, Zimbabwe — Florence Makumene held a plastic container of HIV medication and wondered whether it would be her last as fears swelled of a return to a time decades ago when millions across ...

National Week of Prayer for the Healing of AIDS brings faith communities together for prayer, education, and advocacy to ...

South Africa's National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country.